Hypertension is the most prevalent modifiable risk factor for cardiovascular disease and for cardiovascular and all­cause mortality globally. Suboptimal control of elevated blood pressure places a substantial burden on health­care systems worldwide. Several factors contribute to this suboptimal control, such as limited awareness of hypertension, lack of appropriate diagnosis and poor control of blood pressure among those with a diagnosis. These factors can be due to patient non­adherence to treatment, inertia among health­care professionals and low uptake and implementation of clinical guideline recommendations. From 2003 to 2018, the European Society of Hypertension and the European Society of Cardiology jointly published four sets of guidelines on hyper tension. However, the two societies released separate guidelines on hypertension in 2023 and 2024, respectively. These two sets of European guidelines agree on most recommendations, but some differences have been identified. In this Expert Recommendation, we highlight the key consensus recommendations from the two guidelines; compare differing approaches to the definition, classification, diagnosis and treatment of hypertension; and aim to help health­care professionals in their decision­making to improve the management of hypertension and to reduce the burden of
hypertension­associated outcomes and premature deaths.

Read full article (July 2025 Nature Reviews Cardiology) here!